BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31385358)

  • 1. Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral.
    Moccia M; Prados F; Filippi M; Rocca MA; Valsasina P; Brownlee WJ; Zecca C; Gallo A; Rovira A; Gass A; Palace J; Lukas C; Vrenken H; Ourselin S; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Barkhof F;
    Ann Neurol; 2019 Nov; 86(5):704-713. PubMed ID: 31385358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalised boundary shift integral for longitudinal assessment of spinal cord atrophy.
    Prados F; Moccia M; Johnson A; Yiannakas M; Grussu F; Cardoso MJ; Ciccarelli O; Ourselin S; Barkhof F; Wheeler-Kingshott C
    Neuroimage; 2020 Apr; 209():116489. PubMed ID: 31877375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord atrophy in a primary progressive multiple sclerosis trial: Improved sample size using GBSI.
    Moccia M; Valsecchi N; Ciccarelli O; Van Schijndel R; Barkhof F; Prados F
    Neuroimage Clin; 2020; 28():102418. PubMed ID: 32961403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
    Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
    Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
    Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
    Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
    Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability.
    Bussas M; El Husseini M; Harabacz L; Pineker V; Grahl S; Pongratz V; Berthele A; Riederer I; Zimmer C; Hemmer B; Kirschke JS; Mühlau M
    Neuroimage Clin; 2022; 34():103006. PubMed ID: 35468568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
    Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
    Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.
    Cawley N; Tur C; Prados F; Plantone D; Kearney H; Abdel-Aziz K; Ourselin S; Wheeler-Kingshott CAG; Miller DH; Thompson AJ; Ciccarelli O
    Mult Scler; 2018 Jun; 24(7):932-941. PubMed ID: 28516804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Casserly C; Seyman EE; Alcaide-Leon P; Guenette M; Lyons C; Sankar S; Svendrovski A; Baral S; Oh J
    J Neuroimaging; 2018 Nov; 28(6):556-586. PubMed ID: 30102003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.
    Bonacchi R; Pagani E; Meani A; Cacciaguerra L; Preziosa P; De Meo E; Filippi M; Rocca MA
    Radiology; 2020 Sep; 296(3):605-615. PubMed ID: 32573387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
    Valsasina P; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Yiannakas M; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Filippi M; Rocca MA;
    Mult Scler; 2022 May; 28(6):885-899. PubMed ID: 34605323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
    Rocca MA; Valsasina P; Damjanovic D; Horsfield MA; Mesaros S; Stosic-Opincal T; Drulovic J; Filippi M
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):35-41. PubMed ID: 23064100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes.
    Bernitsas E; Bao F; Seraji-Bozorgzad N; Chorostecki J; Santiago C; Tselis A; Caon C; Zak I; Millis S; Khan O
    Mult Scler Relat Disord; 2015 Jan; 4(1):47-51. PubMed ID: 25787052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
    Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
    Biberacher V; Boucard CC; Schmidt P; Engl C; Buck D; Berthele A; Hoshi MM; Zimmer C; Hemmer B; Mühlau M
    Mult Scler; 2015 Jun; 21(7):875-84. PubMed ID: 25139943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Assessment of Longitudinal Spinal Cord Atrophy in Multiple Sclerosis Using a Registration-Based Approach: Relevance for Clinical Studies.
    Valsasina P; Horsfield MA; Meani A; Gobbi C; Gallo A; Rocca MA; Filippi M
    J Magn Reson Imaging; 2022 May; 55(5):1559-1568. PubMed ID: 34582062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease.
    Azevedo CJ; Cen SY; Khadka S; Liu S; Kornak J; Shi Y; Zheng L; Hauser SL; Pelletier D
    Ann Neurol; 2018 Feb; 83(2):223-234. PubMed ID: 29328531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis.
    Yiannakas MC; Mustafa AM; De Leener B; Kearney H; Tur C; Altmann DR; De Angelis F; Plantone D; Ciccarelli O; Miller DH; Cohen-Adad J; Gandini Wheeler-Kingshott CA
    Neuroimage Clin; 2016; 10():71-7. PubMed ID: 26793433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper cervical spinal cord cross-sectional area in relapsing remitting multiple sclerosis: application of a new technique for measuring cross-sectional area on magnetic resonance images.
    Mann RS; Constantinescu CS; Tench CR
    J Magn Reson Imaging; 2007 Jul; 26(1):61-5. PubMed ID: 17659556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.